Search Results for: car t

Noncommunicable diseases (NCDs) enjoy a place of prominence on the global public health agenda in 2011. At the 128th WHO EB, the assembly was abuzz with news of a joint Russian and WHO initiative, the “First global ministerial conference on healthy lifestyles and noncommunicable disease control” to be held in Moscow on 28-29 April 2011 and the UN High-level Meeting of the General Assembly on Non-Communicable Diseases in September 2011.

Continue Reading →

Today, Tibotec, a subsidiary of Johnson & Johnson, announced it has signed voluntary licensing agreements with several Indian and South African generic companies to allow generic competition on a new HIV-AIDS treatment, the investigational non-nucleoside reverse transcriptase inhibitor rilpivirine hydrochloride (TMC278) (rilpivirine hydrochloride), to certain developing countries. Continue Reading →

The following is an article by Agathe Duparc which appeared on page four of the Sunday/Monday edition (23 January-24 January 2011) of Le Monde with a reference on the cover page. Below the article are two paragraphs providing readers with more background information on the World Health Assembly and the Executive Board. The third paragraph is the main quote highlighted in the print version. What is missing in this copy below is a cartoon accompanying the piece which shows a bespectacled man with a body of an octopus holding two syringes in a field of dollar signs. Continue Reading →

WHO has kindly made available its conflict of interest guidelines. Apparently they are not available from the public web page. Attached are two documents:

• Conflict of Interest Guidelines and Procedures
• Declaration of Interests for WHO Experts

A few of the many interesting provisions follow:

I. MEANING OF “CONFLICT OF INTEREST”

Continue Reading →

Knowledge Ecology International (KEI) has received a copy of U.S. industry demands on the Intellectual Property chapter of the Trans-Pacific Partnership Agreement (TPP) negotiations. A draft letter from US industry to USTR has been leaked and is available here.

Continue Reading →

25 November 2010

The fourth day of WIPO’s Committee on Development and Intellectual Property(CDIP6) has witnessed a rich discussion on how to implement Recommendation 36 of the WIPO Development Agenda which states:

Recommendation 36 (Cluster D): To exchange experiences on open collaborative projects such as the Human Genome Project as well as on intellectual property models

Continue Reading →

The 6th session of the WIPO Advisory Committee on Enforcement is taking place in Geneva from 1-2 December 2010. KEI’s observations on the 5th session, entitled, Positive outcome reached at WIPO Advisory Committee on Enforcement while ACTA looms in the East can be found here:/node/681.

Continue Reading →